Abstract
Background
Serous cystic neoplasms of the pancreas are regarded as a benign entity with rare malignant potential. Surgical resection is generally considered curative.
Objective
To perform the largest single institution review of patients who underwent surgical resection for serous cystic neoplasms of the pancreas in the hopes of guiding future management.
Methods
Between June 1988 and January 2005, 158 patients with serous cystic neoplasms of the pancreas underwent surgical resection. A retrospective analysis was performed. Univariate and multivariate models were used to determine factors influencing perioperative morbidity and mortality. Major complications were defined as pancreatic fistula or anastomotic leak, postoperative bleed, retained operative material, or death. Minor complications were defined as wound infection, postoperative obstruction/ileus requiring total parenteral nutrition (TPN), delayed gastric emptying, arrhythmia, or other infection.
Results
The mean age of the patients was 62.1 years, with 75% being female. The majority of patients were symptomatic at presentation (63%), with abdominal pain as the most common symptom. Of the 158 patients, 75 underwent distal pancreatectomy, 65 underwent pancreaticoduodenectomy, nine underwent central pancreatectomy, five underwent local resection or enucleation, and four underwent total pancreatectomy. Mean tumor diameter was 5.1 cm. Mean operative time was 277 min. Mean postoperative length of hospital stay was 11 days. One patient was diagnosed at presentation with serous cystadenocarcinoma. The remaining 157 patients were initially diagnosed with benign serous cystadenoma. One of three patients with locally aggressive benign disease later presented with metastatic disease. Resection margins for all 158 patients were negative for tumor, and only one (0.6%) showed lymph node involvement. There was one intraoperative death. The incidence of major perioperative complications was 18%, whereas the incidence of minor complications was 33%. Men were significantly more likely to experience minor perioperative complications (OR = 3.74, P = 0.008), whereas patients greater than 65 years showed a trend toward fewer major complications (OR = 0.36, P = 0.09).
Conclusions
Surgically resected serous cystic neoplasms of the pancreas are typically seen in asymptomatic women as 5 cm neoplasms and are predominantly benign. Most are resected via either a left- or right-sided pancreatectomy with low mortality risk, but with notable major or minor morbidity. Cystadenocarcinoma is a rare finding on initial resection of serous cystic neoplasms. However, initial pathology specimens exhibiting benign but locally aggressive neoplasia may indicate an increased likelihood of recurrence or metachronous metastasis, although this claim is limited by a small patient subpopulation in this study and warrants further review.
Similar content being viewed by others
References
Kosmahl M, Wagner J, Peters K et al. Cystic neoplasms of the pancreas: an immunohistochemical analysis revealing alpha-inhibin, neuron-specific enolase, and MUC6 as new markers. Am J Pathol 2004;28:339–346.
Horvath KD, Chabot JA. An aggressive resectional approach to cystic neoplasms of the pancreas. Am J Surg 1999;178:269–274.
Owen DA, Kelly JK. Pathology of the Gall Bladder, Biliary Tract, and Pancreas. Philadelphia: Sunders, 2001, vol 39, p 154.
Megibow AJ, Lombardo FP, Guiarise A et al. Cystic masses: cross-sectional imaging observations and serial follow-up. Abdom Imaging 2001;26:640–647.
Fernandez-del Castillo C, Targarona J, Thayer SP et al. Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients. Arch Surg 2003;138:424–427.
Winter JH, Cameron JL, Lillemoe KD et al. Periampullary and pancreatic incidentaloma: a single institution’s experience with an increasingly common diagnosis. Ann Surg 2006;243(5):673–683.
Pyke CM, van Heerden JA, Colby TV, Sarr MG, Weaver AL. The spectrum of serous cystadenoma of the pancreas. Clinical, pathologic, and surgical aspects. Ann Surg 1992;215:132–139.
Le Borgne J, de Chalan L, Partensky C. Cystadenomas and cystadenocarcinoma of the pancreas: a multiinstitutional and retrospective study of 398 cases. French Surgical Association. Ann Surg 1999;230:152–161.
Capella C, Solcia E, Kloppel G, Hruba RH. Serous cystic neoplasms of the pancreas. In: Hamilton SR, Aaltonen LA, eds. World Health Organization Classification of Tumors. Pathology and Genetics of Tumours of the Digestive Tract. Lyon: IARC Press, 200:231–233.
George DH, Murphy F, Michalski R, Ulmer BG. Serous cystadenocarcinoma of the pancreas: a new entity? Am J Surg Pathol 1989;13:61–66.
Bassi C, Salvia R, Molinari E, Biautti C, Falconi M, Pederzli P. Management of 100 consecutive cases of pancreatic serous cystadenoma: wait for images and see at imaging or vice versa? World J Surg 2003;27:319–323.
Strobel O, Z’graggen K, Schmitz-Winnentha FH et al. Risk of malignancy in serous cystic neoplasms of the pancreas. Digestion 2003;68:24–33.
Siech M, Tripp K, Schmidt-Rohlfing B, et al. Cystic tumors of the pancreas: diagnostic accuracy, pathologic observations, and surgical consequences. Langenbecks Arch Surg 1998;383:56–61.
Tseng J, Warshaw A et al. Serous Cystadenoma of the pancreas: tumor growth rates and recommendations for treatment. Ann Surg 2005;242:413–421.
Compagno J, Oertel JE. Microcystic adenomas of the pancreas (glycogen-rich cystadenomas): a clinicopathologic study of 34 cases. Am J Clin Pathol 1978;69:289–298.
Hodgkinson DJ, ReMine WH, Weiland LH. Pancreatic cystadenoma. A clinicopathologic study of 45 cases. Arch Surg 1978;113:512–519.
Matsumoto T et al. Malignant serous cystic neoplasm of the pancreas. J Clin Gastroenterol 2005;39:253–256.
Ohta T, Nagakawa T, Itho H et al. A case of serous cystadenoma of the pancreas with focal malignant changes. Int J Pancreatol 1993;14:283–289.
Eriguchi N, Aoyagi S, Nakayama T et al. Serous cystadenocarcinoma of the pancreas with liver metastases. J Hepatobiliary Pancreat Surg 1998;5:467–470.
Abe H, Kubota K, Mori M et al. Serous cystadenoma of the pancreas with invasive growth: benign or malignant? Am J Gastroenterol 1998;93:1963–1966.
Brenin DR, Talamonti MS, Yang EY et al. Cystic neoplasms of the pancreas. A clinicopathologic study, including DNA flow cytometry. Arch Surg 1995;130:1048–1054.
Okata T, Nonami T, Miwa T et al. Hepatic metastasis of serous cystadenocarcinoma resected 4 years after operation—a case report. Nippon Shokakibyo Gakkai Zasshi 1991;88:2719–2723.
Wu, CM, Hruban RH, Fishman EK, Schlott WD, Cameron JL. Serous cystic neoplasm of the pancreas involving the pancreas and liver: an unusual clinical entity. Abdom Imaging 1999;24:75–77.
Hruban RH, Klimstra DS, Pitman MB. Atlas of tumor pathology. Tumors of the Pancreas. 4th Series. Washington, DC: American Institute of Pathology; 2006.
Sohn TA, Yeo CJ, Cameron JL et al. Resected adenocarcinoma of the pancreas—616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 2000;4(6):567–579.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Galanis, C., Zamani, A., Cameron, J.L. et al. Resected Serous Cystic Neoplasms of the Pancreas: A Review of 158 Patients with Recommendations for Treatment. J Gastrointest Surg 11, 820–826 (2007). https://doi.org/10.1007/s11605-007-0157-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-007-0157-4